Related Experiment Video
Updated: Nov 8, 2025
08:41
Investigating the Phagocytosis of Leishmania using Confocal Microscopy
Published on: July 29, 2021
4.2K
Extracellular vesicles and leishmaniasis: Current knowledge and promising avenues for future development
George Dong1, Victoria Wagner2, Aida Minguez-Menendez3
1Infectious Diseases and Immunology in Global Health Program (IDIGH), The Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
Molecular Immunology
|April 19, 2021
Summary
Extracellular vesicles (EVs) are crucial in cell communication and disease. Leishmania EVs worsen disease and may cause drug resistance, but also offer potential for vaccines and biomarkers.
Area of Science:
- Cell Biology
- Parasitology
- Immunology
Background:
- Extracellular vesicles (EVs) are key mediators of intercellular communication.
- EVs transfer macromolecules, influencing recipient cell physiology and disease processes.
- Leishmaniasis, a parasitic disease, involves Leishmania and its EVs.
Purpose of the Study:
- To review recent advancements in Extracellular Vesicle (EV) research.
- To focus on the specific role of Leishmania EVs in disease.
- To explore the potential clinical applications of EVs.
Main Methods:
- Literature review of current research on Extracellular Vesicles (EVs).
- Analysis of studies investigating Leishmania parasite and its EVs.
- Synthesis of findings on EV roles in disease pathogenesis and drug resistance.
Main Results:
- Leishmania EVs contribute to disease exacerbation.
- Leishmania EVs are implicated in the development of drug resistance.
- EVs show promise as biomarkers for disease and drug resistance.
- EVs are being explored for vaccine development.
Conclusions:
- Extracellular vesicles (EVs) play a significant role in Leishmania pathogenesis.
- Leishmania EVs present opportunities for novel diagnostic and therapeutic strategies.
- Further research into EVs could lead to new treatments and vaccines for leishmaniasis.
Related Concept Videos
01:38Intralumenal Vesicles and Multivesicular Bodies
4.2K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.2K
01:36Overview of Exosomes
3.1K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.1K
01:20Receptor-mediated Endocytosis
7.0K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.0K